Timing blood thinners after head injury: a delicate balance between bleeding and stroke risk

NCT ID NCT06322953

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial investigates the safest time to restart direct oral anticoagulants (DOACs) after a traumatic brain bleed. Many older adults who fall and hit their head are on blood thinners for conditions like atrial fibrillation, and stopping them raises the risk of stroke or clots. The study will compare restarting DOACs at 1 week versus 4 weeks after injury, tracking major bleeding or clotting events over 12 weeks. About 1,084 participants will be followed to see which timing offers the best balance of safety and protection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Direct oral anticoagulants (DOACs) such as apixaban, dabigatran, edoxaban, or rivaroxaban

What this could lead to

If it works, this could establish the safest time to restart blood thinners after a head injury, reducing the risk of both further bleeding and strokes.

What could go wrong

This is a single trial, and results may not apply to all patients. There is still a risk of bleeding or clotting regardless of timing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMATIC INTRACRANIAL HAEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Intracranial Hemorrhage, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Walton Centre NHS Foundation Trust

    RECRUITING

    Liverpool, Mersyside, L9 7LJ, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospitals Plymouth NHS Trust

    RECRUITING

    Plymouth, Devon, PL6 8DH, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••